Skip to main content
Log in

Oft diagnostiziert – aber immer richtig therapiert?

Influenza

  • FORTBILDUNG_ÜBERSICHT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Zusammenfassung

Die Influenza ist eine Orthomyxovireninfektion und tritt seit hunderten von Jahren epidemisch und immer wieder pandemisch auf. Das klinische Spektrum reicht von asymptomatischen Infektionen über unkomplizierte obere Atemwegsinfektionen bis hin zu schweren Organkomplikationen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Shope RE. Swine Influenza: I. Experimental Transmission and Pathology. The Journal of experimental medicine 1931;54:349–59.

    Article  PubMed  CAS  Google Scholar 

  2. Treanor JJ. Influenza Viruses including Avian Influenza and Swine Influenza. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett’s Principles and Practices of Infectious Diseases. Philadelphia: Churchill Livingstone Elsevier; 2010:2265–88.

    Chapter  Google Scholar 

  3. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008;358:261–73.

    Article  PubMed  CAS  Google Scholar 

  4. Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008;371:1464–75.

    Article  PubMed  CAS  Google Scholar 

  5. CDC. Avian Influenza A Virus Infections in Humans. http://wwwcdcgov/flu/avianflu/avian-in-humanshtm Accessed on July 21, 2013.

  6. Brankston G, Gitterman L, Hirji Z, Lemieux C, Gardam M. Transmission of influenza A in human beings. The Lancet infectious diseases 2007;7:257–65.

    Article  PubMed  Google Scholar 

  7. Rohde GG. [Influenza: clinical symptoms, diagnostics and therapy]. Der Internist 2011;52:1047–52.

    Article  PubMed  CAS  Google Scholar 

  8. Zambon MC. The pathogenesis of influenza in humans. Rev Med Virol 2001;11:227–41.

    Article  PubMed  CAS  Google Scholar 

  9. Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Critical care medicine 2010;38:e91–7.

    Article  PubMed  Google Scholar 

  10. Tasher D, Stein M, Simoes EA, Shohat T, Bromberg M, Somekh E. Invasive bacterial infections in relation to influenza outbreaks, 2006-2010. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2011;53:1199–207.

    Article  Google Scholar 

  11. Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. The Lancet infectious diseases 2009;9:601–10.

    Article  PubMed  Google Scholar 

  12. STIKO. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert-Koch-Institut /Stand Juli 2012. Epidemiologisches Bulletin 2012;30:283–309.

    Google Scholar 

  13. Mullooly JP, Barker WH, Nolan TF, Jr. Risk of acute respiratory disease among pregnant women during influenza A epidemics. Public Health Rep 1986;101:205–11.

    PubMed  CAS  Google Scholar 

  14. Richards JL, Hansen C, Bredfeldt C, et al. Neonatal outcomes after antenatal influenza immunization during the 2009 H1N1 influenza pandemic: impact on preterm birth, birth weight, and small for gestational age birth. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2013;56:1216–22.

    Article  Google Scholar 

  15. Fezeu L, Julia C, Henegar A, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obesity reviews: an official journal of the International Association for the Study of Obesity 2011;12:653–9.

    Article  CAS  Google Scholar 

  16. WHO. WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and other Influenza Viruses 2010.

    Google Scholar 

  17. Lee N, Chan PK, Hui DS, et al. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009;200:492–500.

    Article  PubMed  Google Scholar 

  18. Louie JK, Yang S, Acosta M, et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2012;55:1198–204.

    Article  CAS  Google Scholar 

  19. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013;207:553–63.

    Article  PubMed  CAS  Google Scholar 

  20. Perelson AS, Rong L, Hayden FG. Combination antiviral therapy for influenza: predictions from modeling of human infections. J Infect Dis 2012;205:1642–5.

    Article  PubMed  CAS  Google Scholar 

  21. Recommended composition of influenza virus vaccines for use in the 2013-14 northern hemisphere influenza season. 2013. (Accessed 17.07.2013, at http://www.who.int/influenza/vaccines/virus/recommendations/2013_14_north/en/index.html.)

  22. WHO. Clinical management of human infection with avian influenza A (H5N1) virus. http://wwwwhoint/influenza/resources/documents/clinical_management_h5n1_15_08_2007/en/indexhtml (Accessed on July 21, 2013).

  23. WHO. RISK ASSESSMENT - Human infections with avian influenza A(H7N9) virus. http://www.who.int/influenza/human_animal_interface/influenza_h7n9/RiskAssessment_H7N9_07Jun13.pdf: WHO.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernd Salzberger.

Additional information

Interessenskonflikt

Die Autoren erklären, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten ließen. Sie legen folgende potenzielle Interessenkonflikte offen: Honorare für Vorträge und Beratungen (Advisory Board) von GSK erhalten. Klinische Studien in Kooperation mit den Firmen Biochryst und GSK. Der Verlag erklärt, dass die inhaltliche Qualität des Beitrags von zwei unabhängigen Gutachtern geprüft wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung. Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere für Präparate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bauernfeind, S., Salzberger, B. Oft diagnostiziert – aber immer richtig therapiert?. MMW - Fortschritte der Medizin 155, 43–50 (2013). https://doi.org/10.1007/s15006-013-2123-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-013-2123-2

Keywords - Influenza

Navigation